TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase

Journal of Autoimmunity

Volumn 37, Issue 3, 2011, Pages 190-197

  Séité, Jean François ^a,b   Guerrier, Thomas ^a,b   Cornec, Divi ^a,b   Jamin, Christophe ^a,b   Youinou, Pierre ^a,b   Hillion, Sophie ^a,b  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmune diseases; B lymphocyte; Intravenous immunoglobulin; TLR9

Indexed keywords

CD22 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; PHOSPHATASE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION;

AMINO ACID SEQUENCE; ANTIGENS, CD22; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 80755153560     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.05.014     Document Type: Article

References (51)

1. Lemieux R., Bazin R., Néron S. Therapeutic intravenous immunoglobulins. Mol Immunol 2005, 42:839-848.
2. Kaveri S.V., Lacroix-Desmazes S., Bayry J. The antiinflammatory IgG. N Engl J Med 2008, 359:307-309.
3. Zandman-Goddard G., Blank M., Shoenfeld Y. IVIg in systemic lupus erythematosus: from the bench to the bedside. Lupus 2009, 18:884-888.
4. de Grandmont M.J., Racine C., Roy A., Lemieux R., Néron S. IVIg induces the in vitro differentiation of human B lymphocytes and the secretion of IgG. Blood 2003, 101:3065-3073.
5. Prasad N.K., Papoff G., Zeuner A., Bonnin E., Kazatchkine M.D., Ruberti G., et al. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998, 161:3781-3790.
6. McGaha T.L., Karlsson M.C., Ravetch J.V. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 2008, 180:5670-5679.
7. Séïté J.F., Cornec D., Renaudineau Y., Youinou P., Mageed R.A., Hillion S. IVIg modulates BCR-signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 2010, 116:1698-1704.
8. Kawasaki N., Rademacher C., Paulson J.C. CD22 regulates Adaptive and innate immune responses of B cells. J Innate Immun 2010 Dec 17.
9. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
10. Duramad O., Fearon K.L., Chang B., Chan J.H., Gregorio J., Coffman R.L., et al. Inhibitors of TLR9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol 2005, 174:5193-5200.
11. Marta M., Meier U.C., Lobell A. Regulation of autoimmune encephalomyelitis by Toll-like receptors. Autoimmun Rev 2009, 8:506-509.
12. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34:220-225.
13. Manoussakis M.N., Spachidou M.P., Maratheftis C.I. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 2010, 35:212-218.
14. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003, 19:837-847.
15. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., Shlomchik M.J. TLR7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006, 25:417-428.
16. Sadanaga A., Nakashima H., Akahoshi M., Masutani K., Miyake K., Igawa T., et al. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 2007, 56:1618-1628.
17. Summers S.A., Hoi A., Steinmetz O.M., O'Sullivan K.M., Ooi J.D., Odobasic D., et al. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun 2010, 35:291-298.
18. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 1991, 147:1759-1764.
19. Graham K.L., Lee L.Y., Higgins J.P., Steinman L., Utz P.J., Ho P.P. Treatment with a TLR inhibitory CpG-ODN delays and attenuates lupus nephritis in NZB/W mice. Autoimmunity 2010, 43:140-155.
20. Bekeredjian-Ding I.B., Wagner M., Hornung V., Giese T., Schnurr M., Endres S., et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type-I interferon. J Immunol 2005, 174:4043-4050.
21. Hanten J.A., Vasilakos J.P., Riter C.L., Neys L., Lipson K.E., Alkan S.S., et al. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol 2008, 9:39-54.
22. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in TLR signalling. Nat Rev Immunol 2007, 7:353-364.
23. Gay N.J., Gangloff M., Weber A.N. TLRs as molecular switches. Nat Rev Immunol 2006, 6:693-698.
24. Fukao T., Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003, 24:358-363.
25. Li T., Hu J., Li L. Characterization of Tollip protein upon LPS challenge. Mol Immunol 2004, 41:85-92.
26. Kobayashi K., Hernandez L.D., Galán J.E., Janeway C.A., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of TLR signaling. Cell 2002, 110:191-202.
27. Aubin E., Lemieux R., Bazin R. Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation. Blood 2010, 115:1727-1734.
28. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and Ig production in the absence of T-cell help. Blood 2004, 103:3058-3064.
29. Ziegler-Heitbrock H.W., Wedel A., Schraut W., Ströbel M., Wendelgass P., Sternsdorf T., et al. Tolerance to LPS involves mobilization of NFκB with predominance of p50 homodimers. J Biol Chem 1994, 269:17001-17004.
30. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17:677-687.
31. Sly L.M., Rauh M.J., Kalesnikoff J., Song C.H., Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004, 21:227-239.
32. Kim W.U., Sreih A., Bucala R. Toll-like receptors in systemic lupus erythematosus: prospects for therapeutic intervention. Autoimmun Rev 2009, 8:204-208.
33. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., et al. Quantitative expression of TLR1-10 mRNA in cellular subsets of human PBMCs and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4547.
34. Capolunghi F., Cascioli S., Giorda E., Rosado M.M., Plebani A., Auriti C., et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 2008, 180:800-808.
35. Choe J., Choi Y.S. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur J Immunol 1998, 28:508-515.
36. Kessel A., Peri R., Haj T., Snir A., Slobodin G., Sabo E., et al. IVIg attenuates TLR9 activation in B cells from SLE patients. J Clin Immunol 2010 Oct 5.
37. Ruprecht C.R., Lanzavecchia A. TLR stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006, 36:810-816.
38. Barton G.M., Kagan J.C., Medzhitov R. Intracellular localization of TLR9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006, 7:49-56.
39. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005, 115:407-417.
40. Krieg A.M., Yi A.K., Matson S. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
41. Goeckeritz B.E., Flora M., Witherspoon K., Vos Q., Lees A., Dennis G.J., et al. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing ODN motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int Immunol 1999, 11:1693-1700.
42. Herlands R.A., Christensen S.R., Sweet R.A., Hershberg U., Shlomchik M.J. T cell-independent and TLR-dependent antigen-driven activation of autoreactive B cells. Immunity 2008, 29:249-260.
43. Santiago-Raber M.L., Baudino L., Izui S. Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun 2009, 33:231-238.
44. Shen W., Stone K., Jales A., Leitenberg D., Ladisch S. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. J Immunol 2008, 180:4425-4432.
45. Proulx D.P., Aubin E., Lemieux R., Bazin R. Spontaneous internalization of IVIg in activated B cells. Immunol Lett 2009, 124:18-26.
46. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type-I IFN by inhibiting the kinase IRAK1. Nat Immunol 2008, 9:542-550.
47. An H., Zhao W., Hou J., Zhang Y., Xie Y., Zheng Y., et al. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type IFN and proinflammatory cytokine production. Immunity 2006, 25:919-928.
48. Miyake A., Murata Y., Okazawa H., Ikeda H., Niwayama Y., Ohnishi H., et al. Negative regulation by SHPS-1 of TLR-dependent proinflammatory cytokine production in macrophages. Genes Cells 2008, 13:209-219.
49. Jellusova J., Wellmann U., Amann K., Winkler T.H., Nitschke L. CD22 × Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol 2010, 184:3618-3627.
50. Bruhns P., Vely F., Malbec O., Fridman W.H., Vivier E., Daeron M. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by FcγRIIB. J Biol Chem 2000, 275:37357-37364.
51. Massa P.T., Wu C. Increased inducible activation of NFκB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res 1998, 18:499-507.